HitGen Announces License Agreement With Merck & Co., Inc., Kenilworth, NJ USA to Access Compounds for Potential Development of a Novel Class of Drugs

Several novel small molecule lead series with novel profiles for an undisclosed target nominated by Merck & Co., Inc Kenilworth, NJ USA are the subject of this license.